Journal of Translational Medicine,
Journal Year:
2023,
Volume and Issue:
21(1)
Published: Jan. 16, 2023
Abstract
Background
Very
low-calorie
ketogenic
diet
(VLCKD)
has
shown
to
significantly
reduce
body
weight
and
fat
mass,
as
well
inflammation.
These
effects
are
supported
by
nutritional
ketosis,
which
triggers
the
utilization
of
ketone
an
energy
source.
Medium-chain
fatty
acids
(MCTs)
might
serve
potential
enhancers
bodies
production
with
a
greater
effect
on
loss.
Nevertheless,
no
clinical
studies
have
evaluated
MCTs
supplementation
in
addition
VLCKD.
Therefore,
present
study
aimed
evaluate
whether
can
induce
reduction
during
phase
Methods
In
this
retrospective
study,
263
women
overweight/obesity
(body
mass
index,
BMI:
35.7
±
5.3
kg/m
2
)
aged
37.5
14.2
years
followed
one
these
dietary
protocols
for
45
days:
(a)
Control
group,
83
participants
(31.6%)
(VLCKD
without
MCTs),
(b)
VLCKD
+
86
(32.7%)
(MCTs
−
20
g/day-
starting
from
first
day
active
phase),
(c)
earlyMCTs,
94
(35.7%)
g/day-starting
5
days
before
beginning
phase.
Anthropometric
measures,
composition,
c-reactive
protein
(CRP)
concentrations
were
collected
at
end
(45
days)
intervention.
Results
decreased
weight,
BMI,
waist
circumference
compared
control
earlyMCTs
group.
A
two-fold
decrease
increase
muscle
observed
group
As
inflammation,
hs-CRP
(assessed
absolute
percent
change)
lower
(
p
=
0.009)
0.011)
than
logistic
regression
model
showed
that
likelihood
improvement
BMI
classes
(OR:
1.85,
95%
CI
1.02–3.36)
also
after
adjusting
confounding
factors.
Conclusion
(20
g/day)
may
be
useful
tool
enhance
beneficial
mass.
particular,
facilitate
ketosis
thus
contributing
effectiveness
International Journal of Molecular Sciences,
Journal Year:
2020,
Volume and Issue:
21(10), P. 3570 - 3570
Published: May 18, 2020
The
World
Health
Organization
(WHO)
has
recognized
obesity
as
one
of
the
top
ten
threats
to
human
health.
It
is
estimated
that
number
obese
and
overweight
people
worldwide
exceeds
those
who
are
undernourished.
Obesity
not
only
a
state
abnormally
increased
adipose
tissue
in
body,
but
also
release
biologically
active
adipokines.
Adipokines
released
into
circulating
blood,
due
their
specific
receptors
on
surface
target
cells,
act
classic
hormones
affecting
metabolism
tissues
organs.
What
more,
adipokines
cytokines
may
decrease
insulin
sensitivity
induce
inflammation
development
chronic
complications.
Certainly,
it
can
be
stated
an
era
global
pandemic,
gain
more
importance
regards
use
diagnostic
evaluation
treatment
diseases.
An
extensive
search
for
materials
role
white,
brown
perivascular
fatty
obesity-related
metabolic
complications
was
conducted
online
using
PubMed,
Cochrane
database
Embase.
Nutrients,
Journal Year:
2021,
Volume and Issue:
13(5), P. 1654 - 1654
Published: May 13, 2021
Considering
the
lack
of
a
comprehensive,
multi-faceted
overview
ketogenic
diet
(KD)
in
relation
to
health
issues,
we
compiled
evidence
related
use
its
impact
on
microbiome,
epigenome,
diabetes,
weight
loss,
cardiovascular
health,
and
cancer.
The
KD
could
potentially
increase
genetic
diversity
microbiome
ratio
Bacteroidetes
Firmicutes.
epigenome
might
be
positively
affected
by
since
it
creates
signaling
molecule
known
as
β-hydroxybutyrate
(BHB).
has
helped
patients
with
diabetes
reduce
their
HbA1c
need
for
insulin.
There
is
suggest
that
can
help
visceral
adiposity,
appetite
control.
also
suggests
eating
high-fat
improves
lipid
profiles
lowering
low-density
lipoprotein
(LDL),
increasing
high-density
(HDL),
triglycerides
(TG).
Due
Warburg
effect,
used
an
adjuvant
treatment
starve
cancer
cells,
making
them
more
vulnerable
chemotherapy
radiation.
potential
positive
impacts
each
these
areas
warrant
further
analysis,
improved
studies,
well-designed
randomized
controlled
trials
illuminate
therapeutic
possibilities
provided
this
dietary
intervention.
Nutrients,
Journal Year:
2024,
Volume and Issue:
16(15), P. 2436 - 2436
Published: July 26, 2024
Adipose
tissue
(AT),
composed
mainly
of
adipocytes,
plays
a
critical
role
in
lipid
control,
metabolism,
and
energy
storage.
Once
considered
metabolically
inert,
AT
is
now
recognized
as
dynamic
endocrine
organ
that
regulates
food
intake,
homeostasis,
insulin
sensitivity,
thermoregulation,
immune
responses.
This
review
examines
the
multifaceted
adiponectin,
predominant
adipokine
released
by
AT,
glucose
fatty
acid
metabolism.
We
explore
regulatory
mechanisms
its
physiological
effects
potential
therapeutic
target
for
metabolic
diseases
such
type
2
diabetes,
cardiovascular
disease
liver
disease.
Furthermore,
we
analyze
impact
various
dietary
patterns,
specific
nutrients,
physical
activities
on
adiponectin
levels,
highlighting
strategies
to
improve
health.
Our
comprehensive
provides
insights
into
functions
importance
maintaining
systemic
homeostasis.
Nutrition Reviews,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Jan. 14, 2024
Abstract
Context
Despite
the
important
role
of
inflammation-related
factors
on
occurrence
chronic
diseases,
there
is
still
conflicting
evidence
about
effects
ketogenic
diet
(KD)
these
factors.
Objective
In
order
to
obtain
a
better
viewpoint,
this
study
aimed
comprehensively
investigate
KD
markers.
Data
Sources
To
find
pertinent
randomized
controlled
trials
up
August
2023,
databases
including
PubMed/Medline,
Web
Science,
Scopus,
Cochrane
Library,
and
Embase
were
searched.
Extraction
This
included
all
investigating
C-reactive
protein
(CRP),
tumor
necrosis
factor-alpha
(TNF-α),
interleukin
(IL)-6,
IL-8,
IL-10
levels.
Pooled
weighted
mean
difference
(WMD)
95%
confidence
intervals
(CIs)
achieved
by
random-effects
model
analysis
for
best
estimation
outcomes.
Analysis
Forty-four
studies
in
article.
The
pooled
findings
showed
that
has
an
effect
lowering
TNF-α
(WMD:
−0.32
pg/mL;
CI:
−0.55,
−0.09;
P
=
0.007)
IL-6
−0.27
−0.52,
−0.02;
0.036)
compared
with
control
groups.
However,
no
significant
was
reported
others
inflammation
marker–related
results
subgroup
that,
following
≤8
weeks
people
aged
≤50
years,
reduction
levels
significantly
higher
than
other
addition,
body
mass
index
greater
30
kg/m2
≤30
kg/m2,
decreased
extent
after
receiving
KD.
Conclusions
Consequently,
adherence
appears
improve
some
markers
associated
inflammation,
IL-6.
Food and Agricultural Immunology,
Journal Year:
2025,
Volume and Issue:
36(1)
Published: Jan. 16, 2025
The
Very
Low-Energy
Ketogenic
Therapy
(VLEKT)
is
a
structured,
multi-phase
dietary
regimen
characterized
by
carbohydrate
intake
of
less
than
50
g/day
and
daily
caloric
fewer
800
kcal,
which
induces
ketosis
facilitates
significant
weight
loss.
Evidence
suggests
that
this
nutritional
therapy
can
improve
glycemic
control,
lipid
profiles,
blood
pressure,
making
it
promising
option
for
managing
type
2
diabetes
(T2D)
reducing
cardiovascular
risk.
These
benefits
are
achieved
through
reductions
in
triglycerides
low-density
lipoprotein
cholesterol
(LDL-c),
alongside
increases
high-density
(HDL-c).
However,
the
effects
VLEKT
on
metabolism
remain
controversial.
review
emphasizes
urgent
need
further
research
to
validate
long-term
safety
efficacy
VLEKT.
It
also
highlights
critical
role
personalized
plans,
supervised
healthcare
professionals,
optimize
health
outcomes
address
individual
patient
needs.
Nutrients,
Journal Year:
2021,
Volume and Issue:
13(11), P. 3843 - 3843
Published: Oct. 28, 2021
Perivascular
adipose
tissue
(PVAT)
is
an
additional
special
type
of
surrounding
blood
vessels.
Under
physiological
conditions,
PVAT
plays
a
significant
role
in
regulation
vascular
tone,
intravascular
thermoregulation,
and
smooth
muscle
cell
(VSMC)
proliferation.
responsible
for
releasing
adipocytes-derived
relaxing
factors
(ADRF)
perivascular-derived
(PDRF),
which
have
anticontractile
properties.
Obesity
induces
increased
oxidative
stress,
inflammatory
state,
hypoxia,
contribute
to
dysfunction.
The
exact
mechanism
dysfunction
obesity
still
not
well
clarified;
however,
there
are
some
pathways
such
as
renin–angiotensin–aldosterone
system
(RAAS)
disorders
PVAT-derived
factor
dysregulation,
involved
hypertension
endothelial
development.
Physical
activity
has
beneficial
effect
on
function
among
obese
patients
by
reducing
the
stress
state.
Diet,
second
most
non-invasive
strategy
treatment,
may
positive
impact
restore
balance
their
concentration.
Journal of Neurology Neurosurgery & Psychiatry,
Journal Year:
2022,
Volume and Issue:
93(6), P. 637 - 644
Published: April 13, 2022
Background
Dietary
changes
impact
human
physiology
and
immune
function
have
potential
as
therapeutic
strategies.
Objective
Assess
the
tolerability
of
a
ketogenic
diet
(KD)
in
patients
with
relapsing
multiple
sclerosis
(MS)
define
on
laboratory
clinical
outcome
metrics.
Methods
Sixty-five
subjects
MS
enrolled
into
6-month
prospective,
intention-to-treat
KD
intervention.
Adherence
was
monitored
daily
urine
ketone
testing.
At
baseline,
fatigue,
depression
quality
life
(QoL)
scores
were
obtained
addition
to
fasting
adipokines
MS-related
Baseline
metrics
repeated
at
3
and/or
6
months
on-diet.
Results
Eighty-three
percent
participants
adhered
for
study
duration.
Subjects
exhibited
significant
reductions
fat
mass
showed
nearly
50%
decline
self-reported
fatigue
scores.
QoL
physical
health
(67±16
vs
79±12,
p<0.001)
mental
(71±17
82±11,
composite
increased
Significant
improvements
noted
Expanded
Disability
Status
Scale
(2.3±0.9
1.9±1.1,
p<0.001),
6-minute
walk
(1631±302
1733±330
ft,
Nine-Hole
Peg
Test
(21.5±3.6
20.3±3.7
s,
p<0.001).
Serum
leptin
lower
(25.5±15.7
14.0±11.7
ng/mL,
adiponectin
higher
(11.4±7.8
13.5±8.4
µg/mL,
p=0.002)
KD.
Conclusion
KDs
are
safe
tolerable
over
period
yield
body
composition,
depression,
QoL,
neurological
disability
adipose-related
inflammation
persons
living
MS.
Trial
registration
information
Registered
ClinicalTrials.gov
under
number
NCT03718247
,
posted
24
October
2018.
First
patient
enrolment
date:
1
November
Link:
https://clinicaltrials.gov/ct2/show/NCT03718247?term=NCT03718247&draw=2&rank=1
.
Nutrients,
Journal Year:
2022,
Volume and Issue:
14(12), P. 2384 - 2384
Published: June 8, 2022
Ketogenic
Diet
is
a
nutritional
pattern
often
used
as
dietotherapy
in
inflammatory
diseases,
including
neurological
disorders.
Applied
on
epileptic
children
since
1920,
recent
years
it
has
been
taken
into
account
again
tool
to
both
reduce
burdens
and
ameliorate
the
status
of
patients
affected
by
different
pathologies.
Multiple
sclerosis
(MS)
considered
an
immune-mediated
neuro-inflammatory
disease
diet
possible
factor
its
pathogenesis.
The
aim
this
work
investigate
main
potential
targets
MS-related
impairments,
particular
cognitive
deficits,
focusing
alteration
biomarkers
such
Brain
Derived-Neurotrophic
Factor
Tryptophan/Kynurenine
ratio
that
could
play
role
neuroprotection
thus
MS
progression.
Furthermore,
we
here
propose
suggestions
which
are
useful
development
ketogenic
protocol
takes
advantage
anti-inflammatory
properties
low-carbohydrate
foods
from
Mediterranean
be
applied
subjects
with
MS.
In
conclusion,
approach
will
allow
one
develop
combined
modified
improve
neuroinflammation
multiple
sclerosis.
Nutrients,
Journal Year:
2023,
Volume and Issue:
15(14), P. 3120 - 3120
Published: July 12, 2023
The
ketogenic
diet
(KD)
is,
nowadays,
considered
an
interesting
nutritional
approach
for
weight
loss
and
improvement
in
insulin
resistance.
Nevertheless,
most
of
the
studies
available
literature
do
not
allow
a
clear
distinction
between
its
effects
on
sensitivity
per
se,
induced
by
KDs
sensitivity.
In
this
review,
we
discuss
scientific
evidence
direct
mediated
glycemic
status
humans,
describing
KD's
biochemical
background
underlying
mechanisms.
Nutrients,
Journal Year:
2023,
Volume and Issue:
15(20), P. 4468 - 4468
Published: Oct. 21, 2023
Obesity
and
metabolic
dysfunction-associated
steatotic
liver
disease
(MASLD)
are
frequently
associated
conditions
characterized
by
low-grade
inflammation.
Very
low-calorie
ketogenic
diet
(VLCKD)
strategies
commonly
used
to
simultaneously
obtain
weight
loss
an
improvement
of
steatosis.
We
evaluated
the
efficacy
8
weeks'
VLCKD
in
decreasing
white
blood
cell
(WBC)
platelet
(PLT)
counts,
as
well
steatosis
fibrosis,
diagnosed
using
transient
elastography
(FibroScan).
Metabolic
anthropometric
parameters
with
MASLD
were
also
evaluated.
This
study
included
87
participants;
58
women
29
men
aged
between
18
64
years
overweight
(18%)
or
obesity
(82%),
but
not
taking
any
medication.
Anthropometric
measurements,
bioimpedance
analysis,
biochemical
assays
performed
before
after
dietary
intervention.
BMI
(kg/m